Abbott to acquire Cardiovascular Systems for $890 million

Abbott has agreed to acquire Cardiovascular Systems, Inc. (CSI) for $20 per share, with a total equity value of approximately $890 million. CSI's atherectomy system treats peripheral and coronary artery disease.

“The acquisition of CSI will add new, complementary technologies to Abbott's leading vascular device offerings.”abbott.mediaroom.com

• 1 source
• abbott.mediaroom.comAbbott to Acquire Cardiovascular Systems, Inc. - Feb 8, 2023Feb 8, 2023

Summarized from public sources; check the original articles before acting on it.